Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 8/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 6/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 3/20 | 1.00 |
| ▸ | TYR | P14679 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MDM4 | O15151 | 1/20 | 1.00 |
| ▸ | CA1 | P00915 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | CA5A | P35218 | 1/20 | 1.00 |
| ▸ | MDM2 | Q00987 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CA9 | Q16790 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hinokitiol SCHEMBL158795 | 0.83 | TYR (0.71) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27551974 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27478967 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27478148 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27495432 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27551973 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27495431 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27476854 | 0.82 | TYR (0.69) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27495430 | 0.77 | HDAC4 (0.62) | HDAC4HDAC8HDAC2ALOX12TYR | |
| Hinokitiol SCHEMBL27478147 | 0.77 | TYR (0.62) | HDAC4HDAC8HDAC2ALOX12TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 532 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090966-A1 | UROLITHIN COMPOSITIONS | AMAZENTIS SA (CH) | 2026-04-02 | — | — | US | claimed |
| EP-4687859-A2 | DESMOPRESSIN ORAL COMPOSITIONS | TULEX PHARMACEUTICALS, INC. (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024211393-A2 | DESMOPRESSIN ORAL COMPOSITIONS | TULEX PHARMACEUTICALS INC. (US) | 2024-10-10 | — | — | WO | claimed |
| US-20240329536-A1 | COMPOSITION FOR REMOVING EDGE BEAD OF METAL-CONTAINING RESIST, AND METHOD FOR FORMING PATTERN COMPRISING STEP OF REMOVING EDGE BEAD BY USING SAME | SAMSUNG SDI CO., LTD. (KR) | 2024-10-03 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-4376802-A1 | PERSONAL CARE COMPOSITION BASED ON AMINO ACID SURFACTANTS | The Procter & Gamble Company (US) | 2024-06-05 | — | — | EP | claimed |
| EP-4247321-A1 | PERSONAL CARE COMPOSITIONS FREE OF SULFATED SURFACTANTS | The Procter & Gamble Company (US) | 2023-09-27 | — | — | EP | claimed |
| EP-1964544-B2 | Sensitive skin perfumes | TAKASAGO PERFUMERY CO LTD (JP) | 2023-08-02 | — | — | EP | claimed |
| EP-3541355-B1 | MALODOR COUNTERACTANT COMPOSITION AND METHODS | BELL FLAVORS AND FRAGRANCES INC (US) | 2023-06-07 | — | — | EP | claimed |
| US-20230120190-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR FULL MAINTENANCE OF ORAL HEALTH, PROCESS FOR OBTAINING AND USES THEREOF | TEIXEIRA MARCELO RODRIGUES (BR) | 2023-04-20 | — | — | US | claimed |
| EP-3235370-B2 | WOOD FIBRE MAT FOR USE AS PLANT SUBSTRATE | SWISS KRONO Tec AG (CH) | 2022-06-01 | — | — | EP | claimed |
| WO-2022109094-A1 | PERSONAL CARE COMPOSITIONS FREE OF SULFATED SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220160606-A1 | PERSONAL CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2022-05-26 | — | — | US | claimed |
| EP-2874664-B1 | COMPOSITION FOR THERAPEUTIC USE, INCLUDING AN ORGANIC LIPID PHASE AND A RARE-EARTH RADIOISOTOPE COMPLEX | CENTRE EUGENE MARQUIS (FR) | 2019-06-19 | — | — | EP | claimed |
| EP-3349861-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-1964544-B1 | Sensitive skin perfumes | TAKASAGO PERFUMERY CO LTD (JP) | 2017-07-26 | — | — | EP | claimed |
| WO-2017046052-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2017-03-23 | — | — | WO | claimed |
| EP-2110118-B1 | Malodour reducing composition and uses thereof | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| EP-2110118-A1 | Malodour reducing composition and uses thereof | Takasago International Corporation (JP) | 2009-10-21 | — | — | EP | claimed |
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090966-A1 | UROLITHIN COMPOSITIONS | UTS2R, TAS2R30, TAS2R42 | HDAC4 1855/4885HDAC8 2797/4885HDAC2 874/4885 |
| US-20220160606-A1 | PERSONAL CARE COMPOSITION | CUTA, AP3S1, POLR1C | HDAC4 1502/4885HDAC8 2513/4885HDAC2 1428/4885 |
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | AKR1C4, AKR1C3, AKR1C1 | HDAC4 1341/4885HDAC8 4048/4885HDAC2 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.